These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22014019)

  • 21. Role of the innate immune system in the pathogenesis of inflammatory bowel disease.
    van Lierop PP; Samsom JN; Escher JC; Nieuwenhuis EE
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):142-51. PubMed ID: 19179875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of defensins in the pathogenesis of chronic-inflammatory bowel disease].
    Schmid M; Fellermann K; Wehkamp J; Herrlinger K; Stange EF
    Z Gastroenterol; 2004 Apr; 42(4):333-8. PubMed ID: 15095125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate immunity in inflammatory bowel disease: state of the art.
    Hisamatsu T; Ogata H; Hibi T
    Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders.
    Kountouras J; Deretzi G; Gavalas E; Zavos C; Polyzos SA; Kazakos E; Giartza-Taxidou E; Vardaka E; Kountouras C; Katsinelos P; Boziki M; Giouleme O
    Med Hypotheses; 2014 Mar; 82(3):368-73. PubMed ID: 24472867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome.
    Grover M; Herfarth H; Drossman DA
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):48-53. PubMed ID: 18848909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paneth cell defensins and innate immunity of the small bowel.
    Ouellette AJ; Bevins CL
    Inflamm Bowel Dis; 2001 Feb; 7(1):43-50. PubMed ID: 11233660
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial: toll-like receptor expression in irritable bowel syndrome: on the alert for a microbial threat?
    Barbara G
    Am J Gastroenterol; 2011 Feb; 106(2):337-9. PubMed ID: 21301456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Faecal lactoferrin--a novel test to differentiate between the irritable and inflamed bowel?
    Sidhu R; Wilson P; Wright A; Yau CW; D'Cruz FA; Foye L; Morley S; Lobo AJ; McAlindon ME; Sanders DS
    Aliment Pharmacol Ther; 2010 Jun; 31(12):1365-70. PubMed ID: 20331581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammalian defensins in the antimicrobial immune response.
    Selsted ME; Ouellette AJ
    Nat Immunol; 2005 Jun; 6(6):551-7. PubMed ID: 15908936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innate immune signalling at intestinal mucosal surfaces: a fine line between host protection and destruction.
    Cario E
    Curr Opin Gastroenterol; 2008 Nov; 24(6):725-32. PubMed ID: 19122523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunopathogenesis of inflammatory bowel disease: current concepts.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
    Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defensins in innate antiviral immunity.
    Klotman ME; Chang TL
    Nat Rev Immunol; 2006 Jun; 6(6):447-56. PubMed ID: 16724099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome.
    Rijnierse A; Nijkamp FP; Kraneveld AD
    Pharmacol Ther; 2007 Nov; 116(2):207-35. PubMed ID: 17719089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?].
    Mearin F; Perelló A; Balboa A
    Gastroenterol Hepatol; 2009 May; 32(5):364-72. PubMed ID: 19442413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unravelling the pathogenesis of inflammatory bowel disease.
    Xavier RJ; Podolsky DK
    Nature; 2007 Jul; 448(7152):427-34. PubMed ID: 17653185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Structure and function of enteric alpha defensins in norm and pathology].
    Nikitina IG; Bukurova IuA; Krasnov GS; Grineva EN; Karpov VL; Lisitsyn NA; Beresten' SF
    Mol Biol (Mosk); 2012; 46(1):31-6. PubMed ID: 22642099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective antibacterial barrier in inflammatory bowel disease.
    Klag T; Stange EF; Wehkamp J
    Dig Dis; 2013; 31(3-4):310-6. PubMed ID: 24246980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advances in the research of human defensins].
    Peng L; Xu ZN; Fang XM; Qu JM; Cen PL
    Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):261-6. PubMed ID: 15969003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.